Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

VGX-3100 4Light Coagulation 3DNA Methylation 3Colposcopy 3Biopsy 3Watchful Waiting 2Polymerase Chain Reaction 2Observation 2Laser Therapy 2Imiquimod 2Fluorouracil 2Electroporation 2Cidofovir 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1calcipotriene 1Solutions 1Restraint, Physical 1Red Light 1Radiofrequency Ablation 1Probiotics 1Mindfulness-Based Stress Reduction 1Megestrol Acetate 1Mass Screening 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Histological Techniques 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Intraepithelial Lesions × epigallocatechin gallate × Gynecologic × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡